Sotera Health Co (SHC) — SEC Filings
Sotera Health Co (SHC) — 35 SEC filings. Latest: DEFA14A (May 5, 2026). Includes 19 8-K, 5 10-Q, 3 DEFA14A.
View Sotera Health Co on SEC EDGAR
Overview
Sotera Health Co (SHC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 4, 2025: Sotera Health Co (SHC) reported a significant increase in net income for the three months ended September 30, 2025, reaching $48.4 million, a substantial rise from $17.0 million in the prior-year period. Total net revenues grew to $311.3 million, up from $285.5 million in Q3 2024, driven by service
Sentiment Summary
Across 35 filings, the sentiment breakdown is: 33 neutral, 2 mixed. The dominant filing sentiment for Sotera Health Co is neutral.
Filing Type Overview
Sotera Health Co (SHC) has filed 3 DEFA14A, 19 8-K, 5 10-Q, 2 DEF 14A, 2 10-K, 3 SC 13G/A, 1 SC 13G with the SEC between Jan 2024 to May 2026.
Filings by Year
Recent SEC Filings (35)
Risk Profile
Risk Assessment: Of SHC's 24 recent filings, 1 were flagged as high-risk, 9 as medium-risk, and 14 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $311.3M |
| Net Income | $48.4M |
| EPS | $0.17 |
| Debt-to-Equity | 4.78 |
| Cash Position | $299.2M |
| Operating Margin | N/A |
| Total Assets | $3.19B |
| Total Debt | $2.14B |
Key Executives
- Michael J. R. Johnson
- David M. Schlotterbeck
- Michael C. Petras Jr.
Industry Context
Sotera Health operates in the critical healthcare sterilization and lab testing sector. The industry is characterized by high regulatory scrutiny, the need for specialized infrastructure, and a focus on safety and reliability. Key trends include increasing demand for sterilization services due to growing healthcare needs and the complexity of medical devices, alongside ongoing challenges related to environmental compliance and supply chain stability for essential materials like EO and Co-60.
Top Tags
disclosure (6) · regulation-fd (6) · 8-K (4) · financial-obligation (3) · sec-filing (3) · financial-reporting (3) · litigation (3) · financials (3) · 10-Q (3) · Sotera Health (3)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net income for Q3 2025 | $48.4M | Increased from $17.0M in Q3 2024, a 184.7% increase. |
| Total net revenues for Q3 2025 | $311.3M | Increased from $285.5M in Q3 2024, a 9.0% increase. |
| Total net revenues for nine months ended Sep 30, 2025 | $860.2M | Increased from $810.2M in the same period of 2024, a 6.2% increase. |
| Illinois EO litigation settlements | $64.9M | Expense for the nine months ended September 30, 2025. |
| Amortization of intangible assets for Q3 2025 | $3.1M | Decreased significantly from $15.5M in Q3 2024, an 80.0% decrease. |
| Gross profit for Q3 2025 | $177.6M | Increased from $158.0M in Q3 2024, a 12.4% increase. |
| Basic EPS for Q3 2025 | $0.17 | Increased from $0.06 in Q3 2024. |
| Long-term debt as of Sep 30, 2025 | $2.13B | Decreased from $2.21B as of Dec 31, 2024. |
| SEC File Number | 001-39729 | Identifies the company's filing history with the SEC. |
| IRS Employer Identification No. | 47-3531161 | Company's tax identification number. |
| Net Income | $25.3M | Significant improvement from a $10.2M net loss in Q2 2024 |
| New Illinois EO Lawsuits | 1,000 | Filed in Q2 2025, indicating escalating legal risk |
| Total Illinois EO Lawsuits | 10,000 | Cumulative cases as of Q2 2025, highlighting substantial legal exposure |
| Total Georgia EO Lawsuits | 1,000 | Cumulative cases as of Q2 2025, adding to legal burden |
| Service Revenue | $220.5M | Increased from $210.3M in Q2 2024, showing operational growth |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Sotera Health Co (SHC)?
Sotera Health Co has 35 recent SEC filings from Jan 2024 to May 2026, including 19 8-K, 5 10-Q, 3 DEFA14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SHC filings?
Across 35 filings, the sentiment breakdown is: 33 neutral, 2 mixed. The dominant sentiment is neutral.
Where can I find Sotera Health Co SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Sotera Health Co (SHC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Sotera Health Co?
Key financial highlights from Sotera Health Co's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SHC?
The investment thesis for SHC includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Sotera Health Co?
Key executives identified across Sotera Health Co's filings include Michael J. R. Johnson, David M. Schlotterbeck, Michael C. Petras Jr..
What are the main risk factors for Sotera Health Co stock?
Of SHC's 24 assessed filings, 1 were flagged high-risk, 9 medium-risk, and 14 low-risk.
What are recent predictions and forward guidance from Sotera Health Co?
Forward guidance and predictions for Sotera Health Co are extracted from SEC filings as they are enriched.